Healthcare Industry News: Thoratec
News Release - June 15, 2021
Artio Medical Hires Key Sales and Marketing Leaders to Prepare for Commercial Launch of First Product in U.S.PRAIRIE VILLAGE, Kas., June 15, 2021 -- (Healthcare Sales & Marketing Network) -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Jeff Weinrich as Head of Global Sales and Chris Parker as Senior Director of Marketing. Weinrich and Parker have joined Artio to prepare the company for the planned U.S. market release of it first anticipated commercial product, the Solus Gold™ Embolization Device.
Weinrich comes to Artio with over 30 years of senior sales executive experience in the medical device industry. He has a proven track record of executive level sales leadership, building exceptional sales teams and infrastructure, and driving strong, consistent revenue growth. Most recently, Weinrich served as a Senior Regional Sales Manager with Corindus Vascular Robotics where he was instrumental leading physician training, developing national strategic interventional accounts, and strengthening KOL customer relationships, a role he continued with Siemens Healthineers after the acquisition of Corindus. Weinrich has also served on Artio's Board of Directors.
Parker brings over 20 years of commercial experience in the medical device industry, including both sales and marketing roles, and has developed successful marketing campaigns for important blood pump products including the CentriMagTM Circulatory Support System and the HeartMateTM Percutaneous Heart Pump. He comes to Artio from Abbott Vascular where he served as Director of Marketing, leading a large team responsible for global marketing initiatives for a portfolio of products. Prior to Abbott, Parker held marketing roles of increasing responsibility at St. Jude Medical and Thoratec Corporation. His expertise in executing global product launches and market development initiatives will be invaluable as Artio transitions to a commercial stage company.
About Artio Medical
Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. For more information, please visit www.artiomedical.com.
About the Solus Gold TM Embolization Device
Continued blood flow through damaged or diseased blood vessels can result in life-threatening bleeding and other serious medical conditions. Peripheral vascular embolization is a minimally invasive procedure that blocks or reduces flow in blood vessels. The Solus Gold Embolization Device combines a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant for easy delivery, precise placement, and immediate vessel occlusion.
Source: Artio Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.